PlexBio Co., Ltd. (TPEX:6572)

Ligand Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	266.53	278.87	310.36	348.28	315.5
Short-Term Investments	149	149	169	213.5	338.72
Cash & Short-Term Investments	415.53	427.87	479.36	561.78	654.22
Cash Growth	-2.89%	-10.74%	-14.67%	-14.13%	-16.13%
Accounts Receivable	2.61	0.54	1.87	4.47	8.48
Other Receivables	6.89	10.9	14.53	28.65	28.88
Receivables	9.5	11.44	16.4	33.12	37.36
Inventory	68.7	30.33	37.64	50.28	53.37
Prepaid Expenses	41.42	7.66	10.05	34.9	9.7
Other Current Assets	1.18	1.26	4.5	4.8	16.7
Total Current Assets	536.33	478.56	547.94	684.87	771.34
Property, Plant & Equipment	23.82	29.99	27.3	38.94	42.33
Long-Term Investments	8.46	4.01	2.56	5.33	7.04
Other Intangible Assets	0.43	0.69	0.72	0.47	0.78
Other Long-Term Assets	3.33	3.42	3.62	3.2	1.75
Total Assets	572.38	516.66	582.15	732.8	823.23
Accounts Payable	9.86	2.46	2.77	3.26	9.11
Accrued Expenses	12.46	18.25	12.42	17.37	21.71
Current Portion of Leases	3.36	8.42	3.8	7.77	6.12
Current Unearned Revenue	137.12	19.48	17.78	104.18	38.95
Other Current Liabilities	6.12	5.93	9.51	12.03	17.51
Total Current Liabilities	168.92	54.53	46.29	144.61	93.39
Long-Term Leases	2.31	2.44	2.22	1.38	3.37
Long-Term Unearned Revenue	26.74	35.29	43.85	52.49	60.96
Other Long-Term Liabilities	-	-	10.37	-	3.02
Total Liabilities	197.97	92.26	102.72	198.48	160.74
Common Stock	1,036	1,036	1,036	1,036	1,032
Additional Paid-In Capital	637.61	635.53	633.24	632.7	631.17
Retained Earnings	-1,276	-1,213	-1,155	-1,102	-969.98
Comprehensive Income & Other	-23.34	-34.4	-35.61	-33.31	-31.09
Shareholders' Equity	374.41	424.4	479.43	534.32	662.49
Total Liabilities & Equity	572.38	516.66	582.15	732.8	823.23
Total Debt	5.67	10.85	6.02	9.15	9.49
Net Cash (Debt)	409.86	417.02	473.33	552.63	644.73
Net Cash Growth	-1.72%	-11.90%	-14.35%	-14.29%	-16.54%
Net Cash Per Share	3.95	4.02	4.57	5.34	6.26
Filing Date Shares Outstanding	103.65	103.65	103.65	103.65	103.24
Total Common Shares Outstanding	103.65	103.65	103.65	103.65	103.24
Working Capital	367.41	424.03	501.66	540.27	677.95
Book Value Per Share	3.61	4.09	4.63	5.16	6.42
Tangible Book Value	373.98	423.71	478.71	533.85	661.72
Tangible Book Value Per Share	3.61	4.09	4.62	5.15	6.41
Machinery	121.34	112.24	105.48	102.81	99.29
Construction In Progress	-	-	-	0.14	-
Leasehold Improvements	29.23	28.51	28.8	28.43	26.04

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.